CD19 and Platelet storage pool disease: Circulating M-MDSC (CD45 + CD19-CD11b + Ly6C +) were lowest in the SPD group (4.9 × 105 cells/μL blood) and were significantly reduced compared to anti-mCTLA-4 (p < 0.001).